Promega
Promega, QuantumCyte Ink Comarketing Agreement
The companies are combining QuantumCyte's QCPrecise and Promega's Maxwell CSC and ReliaPrep kits into an integrated clinical lab workflow.
Promega to Develop Microsatellite Instability Companion Diagnostic Kit With GlaxoSmithKline
The IVD kit will be used to identify patients with the MSI biomarker who may be eligible for potential treatment with GSK's Jemperli (dostarlimab-gxly).
Inoviq, Promega to Comarket Exosome Isolation, Nucleic Acid Purification Solutions
The initial agreement is for a term of three years, and the firms expect to expand the deal to cover additional technologies in the future.
Stilla Technologies, Promega Ink Comarketing Deal for Digital PCR
The firms will combine Promega's Maxwell nucleic acid extraction systems and Stilla's six-color Naica digital PCR platform and create a workflow for different applications.
Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug
The companies aim to develop the companion diagnostic for use with Henlius' investigational treatment for microsatellite instability-high solid tumors.